Synovis Life Technologies, Inc. Names Daniel L. Mooradian Vice President of Research and Development

ST. PAUL, Minn.--(BUSINESS WIRE)--Synovis Life Technologies, Inc. (NASDAQ: SYNO), a diversified medical device company, has named Daniel L. Mooradian, Ph.D., vice president of research and development, effective today. Mooradian is returning to Synovis, where he was director of research and development and principal scientist from 2001 to 2004. He succeeds recently retired B. Nicholas Oray, Ph.D., vice president of research and development for the last 10 years.
MORE ON THIS TOPIC